No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / therapeutic use*
-
Calcium Channel Blockers / therapeutic use
-
Diabetic Nephropathies / complications
-
Diabetic Nephropathies / drug therapy*
-
Diabetic Nephropathies / prevention & control
-
Diuretics / therapeutic use
-
Drug Therapy, Combination
-
Evidence-Based Medicine*
-
Humans
-
Hypertension / complications*
-
Hypertension / drug therapy*
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / drug therapy*
-
Kidney Failure, Chronic / prevention & control
-
Losartan / therapeutic use
-
Meta-Analysis as Topic
-
Proteinuria / complications
-
Proteinuria / drug therapy
-
Proteinuria / prevention & control
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Diuretics
-
Losartan